Upside – $PROF +19% (preliminary Q3 revenue was about 45%-47% above consensus, with gross margin expected above 70%) – $HAE +14% (no fresh company catalyst confirmed; unusually large move on light premarket volume) – $WOLF +13% (received a conditional commitment for up to $1.5B of 30-year U.S. defense financing, partly offset by warrants for up …
Read in context ›Haemonetics Stock (HAE)
Track Haemonetics stock through TheStreet Pro's latest coverage, including articles, Daily Diary mentions, TheStreet Pro portfolio activity, contributor watchlist signals, and Pro price levels.
HAE
Haemonetics
healthcare
$120.40
â–² +71.48 (+142.28%) past year
Market Cap
$5.55B
P/E Ratio
59.1x
1Y Return
+142.28%
EPS (TTM)
$2.05
Read the latest TheStreet Pro articles mentioning Haemonetics, including market roundups, portfolio updates, trade ideas, and investing analysis.
Articles
0 articlesNo articles mentioning HAE yet.
Daily Diary Mentions
1 mentionUpside, Downside Movers in the Morning